0
BioSpecifics Technologies Corp.
- 1-10 Employees
- Based in Lynbrook, New York
BioSpecifics Technologies Corp., a biopharmaceutical company, engages in the development of an injectable collagenase clostridium histolyticum for multiple indications in the United States. The company offers injectable collagenase for the treatment of Dupuytren’s contracture and Peyronie’s disease under the XIAFLEX brand in Canada, Australia, Brazil, and Mexico, as well as under XIAPEX…More
BioSpecifics Technologies Corp.
Most Recent Responsibility Report
MOST RECENT
Shipping Information
Request Information
BioSpecifics Technologies Corp. does not currently have any hardcopy reports on ResponsibilityReports.com. Click the button below to request a report when hardcopies become available.
Please fill out the form below and click "Place Order" to complete your order.
Our service enables potential investors to review the most recent and archived BioSpecifics Technologies Corp. Sustainability Report, BioSpecifics Technologies Corp. Corporate Social Responsibility Report, BioSpecifics Technologies Corp. CSR Report, BioSpecifics Technologies Corp. Corporate Responsibility, BioSpecifics Technologies Corp. CR Report, BioSpecifics Technologies Corp. Citizenship Report, BioSpecifics Technologies Corp. ESG Report, and BioSpecifics Technologies Corp. Environmental Report online.